CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Non-Hodgkin LymphomaMycosis Fungoides
Interventions
DRUG

CPG 7909

6 mg intratumoral injection, administered immediately before 2 Gy radiotherapy (RT) to a designated tumor lesion, about 24 hours later after a 2nd 2 Gy RT dose, then weekly for 8 additional weeks (total of 10 injections).

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors
All Listed Sponsors
collaborator

Lymphoma Research Foundation

OTHER

collaborator

American Society of Clinical Oncology

OTHER

lead

Ronald Levy

OTHER